Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024 13-05-2024, 16:30

McKinsey & Company’s Annual Global B2B Pulse: Five Omnichannel Strategies Companies are Using to Boost Market Share by 10+ Percent 14-04-2023, 01:07

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21